Insmed Incorporated
LIPO-GLYCOPEPTIDE CLEAVABLE DERIVATIVES AND USES THEREOF

Last updated:

Abstract:

The present invention provides certain lipo-glycopeptide cleavable derivatives and methods for using the same for the treatment of bacterial infections, for example, pulmonary bacterial infections. The LGPC derivatives include a cleavable moiety that in certain embodiments, is designed to allow for cellular uptake and/or a more rapid clearance of the glycopeptide metabolite (i.e., the cleaved glycopeptide) from the site of administration (e.g., the lung) as compared to the uncleaved LGPC.

Status:
Application
Type:

Utility

Filling date:

22 May 2018

Issue date:

21 May 2020